Modular Medical, Inc. (MODD)
| Market Cap | 19.40M -60.8% |
| Revenue (ttm) | n/a |
| Net Income | -26.78M |
| EPS | -14.75 |
| Shares Out | 5.41M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 15,366 |
| Open | 3.870 |
| Previous Close | 3.820 |
| Day's Range | 3.580 - 3.870 |
| 52-Week Range | 3.552 - 30.900 |
| Beta | -0.00 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jun 22, 2026 |
About MODD
Modular Medical, Inc. operates as a medical device company. The company focuses on the design, development, and commercialization of insulin pumps. It also offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. Modular Medical, Inc. is headquartered in San Diego, California.
Financial Performance
Financial StatementsNews
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "From FDA Wins to Scaling Manufacturing - What Investors Should Watch." Featuring Modular Medical CEO - Friday, May 1, 2026
Meet with Modular Medical CEO Jeb Besser There are 4.8 million individuals with diabetes in the US that require daily insulin. Only 20% currently use an insulin pump.
Modular Medical files $150M mixed securities shelf
08:06 EDT Modular Medical (MODD) files $150M mixed securities shelf
Modular Medical Announces Pricing of $3.4 Million Registered Direct Offering of Common Stock
SAN DIEGO, CA / ACCESS Newswire / April 19, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced t...
Modular Medical regains compliance with Nasdaq minimum bid price rule
Modular Medical (MODD) received a letter from the Nasdaq Stock Market notifying the Company that it has regained compliance with the Nasdaq Capital Market’s minimum bid price continued listing require...
Modular Medical regains compliance with Nasdaq minimum bid price rule
Modular Medical (MODD) received a letter from the Nasdaq Stock Market notifying the Company that it has regained compliance with the Nasdaq Capital Market’s minimum bid price continued listing require...
Modular Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
SAN DIEGO, CA / ACCESS Newswire / April 16, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), a leader in innovative, patient-centric insulin delivery, today announced t...
Modular Medical receives FDA 510(k) clearance for Pivot insulin patch pump
Modular Medical (MODD) announced U.S. Food and Drug Administration 510(k) clearance for its next-generation Pivot tubeless insulin patch pump. This milestone clears the path for commercial availabilit...
Modular Medical Receives FDA 510(k) Clearance for Pivot Tubeless Insulin Patch Pump
First Removable 2-Part Design Targets $3 Billion "Almost-Pumper" Market with Expected Q2 2026 initial deployment. Key Milestones & Investment Highlights: FDA 510(k) Clearance Achieved: Pivot™ pump now...
Modular Medical Inc trading halted, news pending
19:50 EDT Modular Medical (MODD) Inc trading halted, news pending
Modular Medical announces 1-for-30 reverse stock split
Modular Medical (MODD) announced that it will effect a 1-for-30 reverse stock split of its outstanding common stock. The common stock is expected to begin trading on a split-adjusted basis…
Modular Medical Announces 1-for-30 Reverse Stock Split
SAN DIEGO, CA / ACCESS Newswire / March 26, 2026 / Modular Medical, Inc. ("Modular Medical" or the "Company") (NASDAQ:MODD), an innovative insulin delivery technology company, today announced that it ...
Modular Medical prices 68.1M shares at 17.62c in public offering
Modular Medical (MODD) announced the pricing of a public offering with new and existing investors of 68,098,000 shares of its common stock and warrants to purchase up to an aggregate…
Modular Medical Announces $12.0 Million Public Offering Priced at a Premium to Market
SAN DIEGO, CA / ACCESS Newswire / March 3, 2026 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump...
Modular Medical files $12M common stock offering
Maxim Group is acting as the sole placement agent for the offering.
Modular Medical starts production of validation lots for Pivot pump set
Modular Medical (MODD) announced the start of production of validation lots for its Pivot tubeless patch pump’s disposable cartridge and infusion set. Achievement of this manufacturing milestone keeps...
Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump
Targeting Q1 2026 Launch, Subject to FDA Clearance Key Highlights: Cartridge & Infusion Set Lots in Production: Validation production lots now being produced for launch, derisking commercial-scale pro...
Modular Medical receives 180-day extension to regain Nasdaq compliance
Modular Medical (MODD) received written notification from the Listing Qualifications Department of the Nasdaq Stock Market, granting the Company’s request for a 180-day extension to regain compliance ...
Modular Medical Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Rule
SAN DIEGO, CA / ACCESS Newswire / December 31, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch ...
Modular Medical Announces Pricing of $4.68 Million Public Offering
SAN DIEGO, CA / ACCESS Newswire / December 10, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch ...
Modular Medical announces common stock and warrant offering, no amount given
Modular Medical (MODD) announced that it has commenced an underwritten public offering of shares of its common stock and warrants to purchase shares of its common stock. The shares of…
Modular Medical Announces Proposed Public Offering
SAN DIEGO, CA / ACCESS Newswire / December 9, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), an insulin delivery technology company with the first FDA-cleared patch pump designed spec...
Modular Medical receives IRB approval for Pivot in-house study
Modular Medical (MODD) announced Institutional Review Board approval to conduct an in-house study of its next-generation Pivot insulin delivery system using insulin on people with diabetes. Pursuant t...
Modular Medical Receives IRB Approval to Deliver Insulin Using Pivot Patch Pump
Study to Deliver Insulin to Internal Testers Wearing Continuous Glucose Monitors SAN DIEGO, CA / ACCESS Newswire / November 17, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Co...
Modular Medical submits Pivot tubeless patch pump for 510(k) clearance
Modular Medical (MODD) announced the 510(k) premarket submission of its next generation Pivot tubeless patch pump to the U.S. Food and Drug Administration. The Company expects to commence the commerci...
Modular Medical Submits Pivot Tubeless Insulin Patch Pump for FDA 510(k) Clearance
-Targets $3 Billion "Almost-Pumper" Market with First Simplified and Removable/Replaceable Insulin Patch Pump - Aims to Improve Patient and Clinician Experience for the Care of Diabetes SAN DIEGO, CA ...